EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

Diabetic retinopathy is a leading cause of vision loss among adults and often goes unnoticed until it reaches advanced stages ...

Diabetes affects more than just the blood sugar. If left unchecked, it can silently threaten your vision too. In India, where ...

It's more than just the sun that can hurt your eyes over time. Health experts say diabetes can also lead to vision loss.

A team of ophthalmology researchers at Stanford University, working with a colleague from New York University School of Medicine, has found that despite promise for detecting diabetic retinopathy, few ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

ABBV-RGX-314, administered once within an office setting, can significantly improve disease severity in patients with NPDR.

KOCHI: 68-year-old Thankamma (name changed) from Ernakulam has been a diabetic patient for 15 years. As she did not manage ...

Research Triangle Park-based Opus Genetics, a clinical-stage gene therapy company devoted to treating inherited retinal ...

The following is a summary of “Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in ...

File Image Google is stepping up its healthcare initiatives by licensing its AI model for diabetic retinopathy detection to key health-tech partners in India and Thailand. The partnerships, involving ...